Switch Therapeutics

San Francisco, United States

Switch Therapeutics is a biotech company that develops RNAi therapies.

$52.0M raised

Mar 2023

Series A

Biotechnology Medical Therapeutics

Top Investors

Insight PartnersGlobal Brain CorporationDigitalis VenturesUpfront VenturesFreeflow Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Switch Therapeutics

How much funding has Switch Therapeutics raised?

Switch Therapeutics has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Who are Switch Therapeutics's investors?

Switch Therapeutics's investors include Insight Partners, Global Brain Corporation, Digitalis Ventures, Upfront Ventures, Freeflow Ventures.

Where is Switch Therapeutics headquartered?

Switch Therapeutics is headquartered in San Francisco, United States.

What does Switch Therapeutics do?

Switch Therapeutics is a biotech company that develops RNAi therapies.

What stage is Switch Therapeutics at?

Switch Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2023.

MLA

"Switch Therapeutics — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/switch-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2023). Switch Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/switch-therapeutics

Wikipedia (cite web)

{{cite web |title=Switch Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/switch-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2023.

Similar Companies in Biotechnology